You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Med., 29 March 2023

Sec. Rheumatology

Volume 10 - 2023 | https://doi.org/10.3389/fmed.2023.1187603

Corrigendum: Editorial: Reviews in rheumatology

  • 1. musculoSKeletal Innovative Research Lab (mSKIL), University of Liège, Liège, Belgium

  • 2. Artialis SA, Liège, Belgium

  • 3. Princess Paola Hospital, Department of Physical Therapy and Rehabilitation, Vivalia, Marche-en-Famenne, Belgium

  • 4. The Osteoarthritis Foundation, Boncelles, Belgium

  • 5. Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary

  • 6. Akasaka Sanno Medical Center, Tokyo, Japan

Article metrics

View details

1k

Views

613

Downloads

In the published article, there was an error in affiliations 4, 5 and 6.

Instead of “5Akasaka Sanno Medical Center, Tokyo, Japan, 6Rheumatology Department, University of Debrecen, Debrecen, Hungary.”

It should be “5Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary, 6Akasaka Sanno Medical Center, Tokyo, Japan.”

And, Instead of “Szekanecz4,5, Masuko5,6,” it should be “Szekanecz5, Masuko6.”

In the published article, there was an error in the Conflict of Interest statement. “YH and ZS were employed by the Osteoarthritis Foundation.” The correct Conflict of Interest statement appears below.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Conflict of interest

YH was employed by the Osteoarthritis Foundation. YH is the founder and executive president of Artialis SA. He has also received consulting fees from Grunenthal, Tilman, Expanscience, Genequine, Allegro, Thuasne, Nestlé, and Ibsa. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

rheumatoid arthritis, systemic lupus erythematosus (SLE), frozen shoulder, cytokines, biomarkers, mitochondria

Citation

Henrotin Y, Szekanecz Z and Masuko K (2023) Corrigendum: Editorial: Reviews in rheumatology. Front. Med. 10:1187603. doi: 10.3389/fmed.2023.1187603

Received

16 March 2023

Accepted

17 March 2023

Published

29 March 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

10 - 2023

Updates

Copyright

*Correspondence: Yves Henrotin

This article was submitted to Rheumatology, a section of the journal Frontiers in Medicine

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics